Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA RECALLS & COURT ACTIONS: Feb. 19, 1992

Executive Summary

CLASS II -- MEPERIDINE HYDROCHLORIDE INJECTION, USP 25 mg/ml, in 1 ml vials, a Rx narcotic analgesic. Recall number: D-213-2. Lot number 061154 EXP 3/93. Manufacturer: Elkins-Sinn, Inc., Cherry Hill, New Jersey. Recalled by: Manufacturer, by letter dated Jan. 20, 1992. Firm-initiated recall ongoing. Distribution: Nationwide. Firm estimates 68,766 vials remain on the market. Reason: A vial of Meperidine was found mislabeled as Robinul Injection. CLASS III -- DIGOXIN TABLETS, USP 0.25 mg, in bottles 1000 and 5000 tablets, a Rx drug under the following labels: Zenith, Aligen, Best Generics, Bioline, Dixon Shane, Goldline, Glenlawn, H.L. Moore Drug Exchange, Interstate Drug Exchange, Rugby, Schein, United Research Laboratories. Recall number: D-212-2. All lots. Manufacturer: Zenith Laboratories, Inc., Northvale, New Jersey. Recalled by: Manufacturer, by letter dated July 17, 1991. Firm-initiated recall ongoing. Distribution: Nationwide. Firm estimates 487 bottles of 1,000 tablets and 50 bottles of 5,000 tablets remain on the market. Reason: Product does not meet dissolution specifications.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS020444

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel